- Home
- AMPX vs MNKD Comparison
AMPX vs MNKD Comparison
Compare AMPX & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMPX | MNKD |
|---|---|---|
| Founded | 2008 | 1991 |
| Country | United States | United States |
| Employees | 108 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | AMPX | MNKD |
|---|---|---|
| Price | $14.82 | $2.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $19.43 | $8.64 |
| AVG Volume (30 Days) | ★ 9.4M | 5.8M |
| Earning Date | 03-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $348,966,000.00 |
| Revenue This Year | $70.54 | $35.81 |
| Revenue Next Year | $66.63 | $11.89 |
| P/E Ratio | ★ N/A | $113.75 |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $1.97 | $2.23 |
| 52 Week High | $19.76 | $6.51 |
Technical Indicators
Market Signals| Indicator | AMPX | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 44.15 | 24.86 |
| Support Level | $10.00 | N/A |
| Resistance Level | $16.03 | $6.18 |
| Average True Range (ATR) | 1.33 | 0.14 |
| MACD | -0.52 | 0.07 |
| Stochastic Oscillator | 3.14 | 24.03 |
Price Performance
Historical ComparisonAbout AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.